Results from MUSIC-HFpEF Phase 1/2a clinical trial show favorable safety profile and early clinical benefits with SRD-002 ...

The istaroxime data will be presented by Jan Biegus MD, Institute of Heart Diseases, Wroclaw Medical University, Wrocław, Poland. The presentation is entitled, "Safety and Efficacy of up to 60 Hours ...

This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the "Act"). Cytokinetics disclaims any intent or obligation to update ...